Phathom Pharmaceuticals (PHAT) Return on Assets (ROA)

Price: $6.6
Market Cap: $459.60M
Avg Volume: 1.12M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.636
52W Range: $4.07-19.71
Website: Phathom Pharmaceuticals

Phathom Pharmaceuticals Return on Assets (ROA) Summary

Phathom Pharmaceuticals's ROA indicates the return generated on the company's assets:

  • Annual: -88.37%
  • Quarterly: -19.68%
  • TTM: -88.37%

What is Return on Assets (ROA)?

Return on Assets (ROA) is a financial ratio that shows the percentage of profit a company earns in relation to its overall resources. It is an indicator of how efficiently a company is using its assets to generate earnings.

Related Metrics

Other important metrics to assess Phathom Pharmaceuticals's profitability include:

  • ROE (Return on Equity) - measures the return generated on shareholders' equity:
    • Annual: 131.84%
    • Quarterly: 29.36%
    • TTM: 162.49%
  • ROIC (Return on Invested Capital) - measures how effectively the company uses its invested capital to generate profits:
    • Annual: -94.51%
    • Quarterly: -20.27%
    • TTM: -94.72%
  • Return on Tangible Assets - measures the return generated on the company's tangible assets:
    • Annual: -88.37%
    • Quarterly: -19.68%
    • TTM: -88.37%
  • Profit Margin - shows the percentage of revenue that has turned into profit:
    • Annual: -605.09%
    • Quarterly: -250.98%
    • TTM: -605.09%

These metrics provide insights into Phathom Pharmaceuticals's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual ROA

-88.37%

Quarterly ROA

-19.68%

TTM ROA

-88.37%

Phathom Pharmaceuticals Historical ROA
33.64%33.64%-25.17%-25.17%-83.98%-83.98%-142.79%-142.79%ROA20192019202020202021202120222022202320232024202420252025
Historical ROE
300.00%300.00%200.00%200.00%100.00%100.00%0.00%0.00%-100.00%-100.00%-200.00%-200.00%-300.00%-300.00%ROE20192019202020202021202120222022202320232024202420252025
Historical ROIC
8.88%8.88%-56.19%-56.19%-121.27%-121.27%-186.35%-186.35%ROIC20192019202020202021202120222022202320232024202420252025
Historical Profit Margin
0.00%0.00%-7000.00%-7000.00%-14000.00%-14000.00%-21000.00%-21000.00%-28000.00%-28000.00%-35000.00%-35000.00%Profit Margin20192019202020202021202120222022202320232024202420252025
Historical Return on Tangible Assets
33.64%33.64%-25.17%-25.17%-83.98%-83.98%-142.79%-142.79%Return on Tangible Assets20192019202020202021202120222022202320232024202420252025

Phathom Pharmaceuticals Historical Profitability Metrics

The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2024.

Year ROA ROE ROIC Profit Margin Return on Tangible Assets
2024 -88.37% 131.84% -94.51% -605.09% -88.37%
2023 -48.71% 277.07% -44.52% -29558.94% -48.71%
2022 -135.31% 298.08% -138.93% 0.00% -135.31%
2021 -78.18% -205.24% -81.08% 0.00% -78.18%
2020 -45.18% -68.62% -52.36% 0.00% -45.18%
2019 -81.56% -92.01% -34.41% 0.00% -81.56%
2018 -142.79% 100.16% -186.35% 0.00% -142.79%

Related Metrics

Explore detailed financial metrics and analysis for PHAT.